TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 18947826

Group type: EXPERIMENTAL
Intervention: Silver yoga exercises (70-min sessions, three times per week for 6 months)
Number of subjects: 128

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 128
Study: 16776701

Group type: EXPERIMENTAL
Intervention: Brush allodynia (BA) tested by cutaneous stimulation with a gauze pad
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Pressure allodynia (PA) tested using von Frey hairs (VFH)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Both BA and PA
Number of subjects: 55
Study: 15342305

Group type: EXPERIMENTAL
Intervention: Propafenone 675 mg/day
Number of subjects: 293

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 293

Group type: EXPERIMENTAL
Intervention: Propafenone (both doses)
Number of subjects: 293
Study: 10944838

Group type: EXPERIMENTAL
Intervention: Improved stoves
Number of subjects: 0

Group type: COMPARATOR
Intervention: Traditional three-stone stoves
Number of subjects: 0
Study: 9067719

Group type: EXPERIMENTAL
Intervention: Sonohysterosalpingography (sono-HSG) utilizing Albunex
Number of subjects: 0

Group type: COMPARATOR
Intervention: X-ray hysterosalpingography (HSG) with standard X-ray contrast media
Number of subjects: 0
Study: 8377337

Group type: EXPERIMENTAL
Intervention: Tissue plasminogen activator (TPA)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Streptokinase (SK)
Number of subjects: 80
Study: 3780128

Group type: EXPERIMENTAL
Intervention: Cimetidine 300 mg
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Cimetidine 400 mg
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Ranitidine 50 mg
Number of subjects: 36
Study: 31569905

Group type: COMPARATOR
Intervention: Commercial vinegars
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Homemade vinegars
Number of subjects: 18
Study: 29926514

Group type: EXPERIMENTAL
Intervention: MYL-1401O
Number of subjects: 132

Group type: COMPARATOR
Intervention: EU-trastuzumab
Number of subjects: 132

Group type: COMPARATOR
Intervention: US-trastuzumab
Number of subjects: 132
Study: 26952681

Group type: EXPERIMENTAL
Intervention: Individualized patient education and emotional support over six weeks.
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (no individualized patient education and emotional support).
Number of subjects: 50
Study: 25332478

Group type: EXPERIMENTAL
Intervention: Lactobacillus paracasei DG (24 billion viable cells daily for 4 weeks)
Number of subjects: 0
Study: 22054033

Group type: EXPERIMENTAL
Intervention: Super Poligrip® Free (cream)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Super Poligrip® Comfort Seal Strips (strip)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: GlaxoSmith Kline Consumer Healthcare (cream)
Number of subjects: 36

Group type: COMPARATOR
Intervention: No adhesive (negative control)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Denture adhesives (all types)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Cream adhesives
Number of subjects: 36
Study: 21111868

Group type: EXPERIMENTAL
Intervention: Confocal laser endomicroscopy (CLE)
Number of subjects: 33
Study: 18573702

Group type: EXPERIMENTAL
Intervention: Tension-free mesh repair (Lichtenstein technique)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Bassini technique
Number of subjects: 54
Study: 16094791

Group type: EXPERIMENTAL
Intervention: Lecture notes combined with structured group discussion (experimental group)
Number of subjects: 169

Group type: COMPARATOR
Intervention: Lecture only (control group)
Number of subjects: 169
Study: 11837527

Group type: EXPERIMENTAL
Intervention: Speech and language therapy interventions
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 9651905

Group type: EXPERIMENTAL
Intervention: HRT-group: Sequential combination of 2 mg estradiol valerate and 1 mg cyproterone acetate + vitamin D3 300 IU/day + calcium lactate 500 mg/day (n = 31)
Number of subjects: 64

Group type: COMPARATOR
Intervention: non-HRT-group: Calcium lactate 500 mg/day + vitamin D3 300 IU/day (n = 33)
Number of subjects: 64
Study: 7898842

Group type: EXPERIMENTAL
Intervention: Intravaginal 2.5 mg of PGE2 gel every hour
Number of subjects: 101

Group type: COMPARATOR
Intervention: Intravaginal 2.5 mg of PGE2 gel every 6 hours
Number of subjects: 101
Study: 2655717

Group type: EXPERIMENTAL
Intervention: Timiperone 1 mg, 3 mg, 6 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sulpiride 100 mg, 300 mg, 600 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: COMPARATOR
Intervention: Haloperidol and Propericiazine (retrospective control)
Number of subjects: 0
Study: 792642

Group type: EXPERIMENTAL
Intervention: Fenoterol (1 mg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Salbutamol
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Orciprenaline
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Isoprenaline
Number of subjects: 0
Study: 30745314

Group type: EXPERIMENTAL
Intervention: High intensity exercise
Number of subjects: 100

Group type: COMPARATOR
Intervention: No-intervention control group
Number of subjects: 100
Study: 30896248

Group type: EXPERIMENTAL
Intervention: Enhanced website
Number of subjects: 350

Group type: COMPARATOR
Intervention: Standard website
Number of subjects: 350
Study: 28835659

Group type: EXPERIMENTAL
Intervention: Azithromycin (3-day course)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study: 26223721

Group type: EXPERIMENTAL
Intervention: Anterior Merocel packing
Number of subjects: 60

Group type: COMPARATOR
Intervention: Internal nasal splint
Number of subjects: 60
Study: 23948601

Group type: EXPERIMENTAL
Intervention: Synthetic oxytocin during labour
Number of subjects: 316
Study: 21785382

Group type: EXPERIMENTAL
Intervention: Radiofrequency (2 watts, 2‐ to 3‐mm depth, cut‐coagulating mode)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Argon laser (spot size 50 μm, 760 mW, 930‐nm wavelengths, continuous)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Radiofrequency
Number of subjects: 100
Study: 19114891

Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC)
Number of subjects: 108

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 108
Study: 16719881

Group type: EXPERIMENTAL
Intervention: Tramadol
Number of subjects: 66

Group type: COMPARATOR
Intervention: Morphine
Number of subjects: 66
Study: 15261713

Group type: EXPERIMENTAL
Intervention: Rater Applied Performance Scale (RAPS)
Number of subjects: 20
Study: 11318574

Group type: EXPERIMENTAL
Intervention: Albendazole 600 mg
Number of subjects: 1186

Group type: COMPARATOR
Intervention: Mebendazole 600 mg (2 doses per year)
Number of subjects: 1186

Group type: COMPARATOR
Intervention: Mebendazole 600 mg (3 doses per year)
Number of subjects: 1186
Study: 9510443

Group type: EXPERIMENTAL
Intervention: Growth hormone treatment (recombinant GH 0.1 IU/kg/day)
Number of subjects: 29

Group type: COMPARATOR
Intervention: No treatment (control group)
Number of subjects: 29
Study: 7802195

Group type: EXPERIMENTAL
Intervention: Omeprazole 40 mg
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Famotidine 40 mg
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study: 3124593

Group type: EXPERIMENTAL
Intervention: High fat intake (450 mg.kg‐1.d‐1) at 60 kcal.kg‐1.d‐1
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Low fat intake (450 mg.kg‐1.d‐1) at 60 kcal.kg‐1.d‐1
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: High fat intake (450 mg.kg‐1.d‐1) at 80 kcal.kg‐1.d‐1
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Low fat intake (450 mg.kg‐1.d‐1) at 80 kcal.kg‐1.d‐1
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Intravenous energy intake ranging from 60 to 80 kcal.kg‐1.d‐1
Number of subjects: 16
Study: 30589391

Group type: EXPERIMENTAL
Intervention: HMB 2-week (3g/day)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: HMB 4-week (3g/day)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 28
Study: 29501590

Group type: EXPERIMENTAL
Intervention: Macitentan 3 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Macitentan 10 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Macitentan (3 mg and 10 mg)
Number of subjects: 0
Study: 26799247

Group type: EXPERIMENTAL
Intervention: Transdermal nicotine patches
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Placebo patches
Number of subjects: 48

Group type: COMPARATOR
Intervention: Continued smoking (20 cigarettes/day)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Never smokers
Number of subjects: 48
Study: 24755123

Group type: EXPERIMENTAL
Intervention: Linagliptin 2.5 mg with 500 mg, 850 mg, or 1,000 mg metformin (FDC)
Number of subjects: 287

Group type: COMPARATOR
Intervention: Individual tablets of linagliptin and metformin (FP)
Number of subjects: 287
Study: 22404601

Group type: EXPERIMENTAL
Intervention: Participation in kidney paired donation (KPD)
Number of subjects: 845

Group type: EXPERIMENTAL
Intervention: Experiences with medical or organ transplant systems
Number of subjects: 845

Group type: COMPARATOR
Intervention: Increased age, male sex, African American race, Hispanic ethnicity, distrust of the medical system, and not understanding organ allocation
Number of subjects: 845
Study: 20854564

Group type: EXPERIMENTAL
Intervention: LiFE programme (balance and strength training embedded in daily life)
Number of subjects: 34

Group type: COMPARATOR
Intervention: No-intervention control group
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: LiFE programme
Number of subjects: 34
Study: 17619862

Group type: EXPERIMENTAL
Intervention: Information emphasizing patch benefits (n = 25)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Nicotine-dose instructions (n = 25)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Control condition (n = 22)
Number of subjects: 72
Study: 16302595

Group type: EXPERIMENTAL
Intervention: Dental program (intervention group)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (children who had never been to a dental office)
Number of subjects: 30
Study: 11838629

Group type: EXPERIMENTAL
Intervention: Paroxetine 20 mg/day
Number of subjects: 384

Group type: EXPERIMENTAL
Intervention: Paroxetine 40 mg/day
Number of subjects: 384

Group type: EXPERIMENTAL
Intervention: Paroxetine 60 mg/day
Number of subjects: 384

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 384
Study: 10023508

Group type: EXPERIMENTAL
Intervention: L-tryptophan 6 g per day
Number of subjects: 37

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 37
Study: 7479300

Group type: EXPERIMENTAL
Intervention: GHRH (50 micrograms)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: SRIF (100 micrograms)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo (sodium chloride 0.9%)
Number of subjects: 12
Study: 2263578

Group type: EXPERIMENTAL
Intervention: Individualized smoking cessation counseling during periodic health examination
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study: 373085

Group type: EXPERIMENTAL
Intervention: tolfenamic acid (100 mg 3 times daily)
Number of subjects: 33

Group type: COMPARATOR
Intervention: phenylbutazone (100 mg 3 times daily)
Number of subjects: 33
Study: 7113925

Group type: EXPERIMENTAL
Intervention: Leader-directed overcorrection group (A)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Leader-participative overcorrection group (P)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard daily safety lecture group (S)
Number of subjects: 0
Study: 31903520

Group type: EXPERIMENTAL
Intervention: Medical students
Number of subjects: 960

Group type: EXPERIMENTAL
Intervention: Vaccinated female students
Number of subjects: 960

Group type: EXPERIMENTAL
Intervention: High-grade clinical students
Number of subjects: 960

Group type: COMPARATOR
Intervention: Nonmedical students
Number of subjects: 960

Group type: EXPERIMENTAL
Intervention: Vaccinated family members or friends
Number of subjects: 960
Study: 31725612

Group type: EXPERIMENTAL
Intervention: Magnifying narrow-band imaging (M-NBI)
Number of subjects: 163

Group type: COMPARATOR
Intervention: Conventional white light (WL) endoscopy
Number of subjects: 163

Group type: EXPERIMENTAL
Intervention: M-NBI
Number of subjects: 163
Study: 28278010

Group type: EXPERIMENTAL
Intervention: Valerian 530 mg capsule twice per day for two months
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo 530 mg capsule (starch)
Number of subjects: 60
Study: 26915963

Group type: EXPERIMENTAL
Intervention: Need supportive (NS) SMS sent twice weekly for 10 weeks
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Need supportive (NS) SMS
Number of subjects: 65

Group type: COMPARATOR
Intervention: Neutral SMS
Number of subjects: 65
Study: 24914136

Group type: COMPARATOR
Intervention: Standard treatment (transfusions/chelation)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Alternative treatment (hydroxyurea/phlebotomy)
Number of subjects: 0
Study: 21761190

Group type: EXPERIMENTAL
Intervention: LipoNasal n nasal spray (LNM)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: LipoNasal n nasal spray and Tears Again eye spray combination therapy (LTC)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Standard cromoglycate combination therapy (CGC)
Number of subjects: 72
Study: 19842004

Group type: EXPERIMENTAL
Intervention: Consulting a curandero
Number of subjects: 3728

Group type: EXPERIMENTAL
Intervention: Praying for healing
Number of subjects: 3728

Group type: EXPERIMENTAL
Intervention: Asking others to pray for healing
Number of subjects: 3728

Group type: EXPERIMENTAL
Intervention: Considering spiritual healing as very important
Number of subjects: 3728
Study: 17227589

Group type: EXPERIMENTAL
Intervention: alpha‐Linolenic Acid Diet (ALA)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Linoleic Acid Diet (LA)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Average American Diet (AAD)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: All diets
Number of subjects: 23
Study: 16002030

Group type: EXPERIMENTAL
Intervention: 21 mg transdermal nicotine patch
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 11941990

Group type: EXPERIMENTAL
Intervention: Adoptive immunotherapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Acyclic retinoid
Number of subjects: 0

Group type: COMPARATOR
Intervention: 131I‐lipiodol
Number of subjects: 0

Group type: COMPARATOR
Intervention: Interferon
Number of subjects: 0
Study: 10628024

Group type: EXPERIMENTAL
Intervention: Teleconsultations
Number of subjects: 132

Group type: COMPARATOR
Intervention: Routine outpatient consultation
Number of subjects: 132
Study: 1807426

Group type: EXPERIMENTAL
Intervention: Fluoride mouthwash program
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (students not participating in the fluoride mouthwash program)
Number of subjects: 0
Study: 6773156

Group type: EXPERIMENTAL
Intervention: Nutritional support, skin protection, and timed surgical intervention
Number of subjects: 63
Study: 31068096

Group type: EXPERIMENTAL
Intervention: ComAlong Toddler parental course
Number of subjects: 0

Group type: COMPARATOR
Intervention: Telephone follow-up
Number of subjects: 0
Study: 30776840

Group type: EXPERIMENTAL
Intervention: Terlipressin
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Somatostatin
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Vasopressin
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Glyceryltrinitrate/Vasopressin
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control (other vasoactive agents)
Number of subjects: 50
Study: 28118559

Group type: EXPERIMENTAL
Intervention: Therapeutic hypothermia (target temperature, 33.0°C)
Number of subjects: 329

Group type: COMPARATOR
Intervention: Therapeutic normothermia (target temperature, 36.8°C)
Number of subjects: 329

Group type: EXPERIMENTAL
Intervention: Therapeutic hypothermia
Number of subjects: 329

Group type: COMPARATOR
Intervention: Therapeutic normothermia
Number of subjects: 329
Study: 25851383

Group type: EXPERIMENTAL
Intervention: Early physical rehabilitation
Number of subjects: 50

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 50
Study: 23868855

Group type: EXPERIMENTAL
Intervention: Trivair Nasal Deposition System delivering anhydrous lactose particles (5 μm and 50 μm at doses of 12.5 mg and 25 mg)
Number of subjects: 12
Study: 20413454

Group type: EXPERIMENTAL
Intervention: Gemfibrozil
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fenofibrate
Number of subjects: 0
Study: 18716761

Group type: EXPERIMENTAL
Intervention: Sildenafil 50 mg
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Sildenafil 100 mg
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study: 17548440

Group type: EXPERIMENTAL
Intervention: NAb-positive patients during treatment months 0-6
Number of subjects: 468

Group type: COMPARATOR
Intervention: NAb-negative patients after month 6
Number of subjects: 468
Study: 16036030

Group type: EXPERIMENTAL
Intervention: Carvedilol (target dosage 25 mg twice daily)
Number of subjects: 3029

Group type: COMPARATOR
Intervention: Metoprolol tartrate (target dosage 50 mg twice daily)
Number of subjects: 3029
Study: 12509205

Group type: EXPERIMENTAL
Intervention: Nonspatial sequence learning (implicit learning)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Stimulus distance (3 cm, 6 cm, 12 cm, or 22 cm)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Subgroup of implicit learners
Number of subjects: 0
Study: 10219066

Group type: EXPERIMENTAL
Intervention: D-chiro-inositol (1200 mg once daily for 6-8 weeks)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study: 7484276

Group type: EXPERIMENTAL
Intervention: Resistance exercise for 18 months
Number of subjects: 56

Group type: COMPARATOR
Intervention: Control group (no exercise)
Number of subjects: 56
Study: 2298863

Group type: EXPERIMENTAL
Intervention: 0.03 mg/kg rhGH
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: 0.06 mg/kg rhGH
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: 0.12 mg/kg rhGH
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: rhGH
Number of subjects: 16
Study: 7191647

Group type: EXPERIMENTAL
Intervention: Bupivacaine 0.75% in 8.25% dextrose, 7.5 mg
Number of subjects: 435

Group type: COMPARATOR
Intervention: Tetracaine, 7.5 mg
Number of subjects: 435

Group type: EXPERIMENTAL
Intervention: Bupivacaine 0.75% in 8.25% dextrose, 12 mg
Number of subjects: 435

Group type: COMPARATOR
Intervention: Tetracaine, 12 mg
Number of subjects: 435

Group type: EXPERIMENTAL
Intervention: Epinephrine added to local anesthetic solution
Number of subjects: 435

Group type: COMPARATOR
Intervention: Tetracaine
Number of subjects: 435
Study: 31952323

Group type: EXPERIMENTAL
Intervention: Hydrotherapy intervention
Number of subjects: 8
Study: 30359438

Group type: EXPERIMENTAL
Intervention: 50 g lactulose
Number of subjects: 32

Group type: COMPARATOR
Intervention: 50 g sucrose (control)
Number of subjects: 32
Study: 27604995

Group type: EXPERIMENTAL
Intervention: IMRT
Number of subjects: 80

Group type: COMPARATOR
Intervention: 3DRT
Number of subjects: 80
Study: 24872554

Group type: EXPERIMENTAL
Intervention: Cued recall paradigm with visual psychophysics and functional neuroimaging
Number of subjects: 0
Study: 22856247

Group type: EXPERIMENTAL
Intervention: Micronutrient fortified biscuits (100 g providing RDA levels of vitamin A, iron, folic acid, vitamin C, and iodine)
Number of subjects: 107

Group type: COMPARATOR
Intervention: Control biscuits (100 g providing 497 kcal and 11.36 g of protein)
Number of subjects: 107
Study: 20399523

Group type: EXPERIMENTAL
Intervention: DAFNE structured education
Number of subjects: 104
Study: 18560697

Group type: EXPERIMENTAL
Intervention: Zinc supplementation (3 mg elemental zinc per day as zinc sulphate)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Zinc supplementation
Number of subjects: 31
Study: 16008116

Group type: EXPERIMENTAL
Intervention: 150 mg EGCG
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 300 mg EGCG
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 12447028

Group type: EXPERIMENTAL
Intervention: Individual cognitive-behavioral therapy (CBT)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Group cognitive-behavioral therapy (CBT)
Number of subjects: 78
Study: 11034937

Group type: EXPERIMENTAL
Intervention: 5 mg testosterone daily by transdermal patch
Number of subjects: 46

Group type: COMPARATOR
Intervention: Matching placebo
Number of subjects: 46
Study: 8679347

Group type: EXPERIMENTAL
Intervention: Cricoid pressure (30 N) applied with neck support
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Cricoid pressure (30 N) applied without neck support
Number of subjects: 50
Study: 2054265

Group type: EXPERIMENTAL
Intervention: Magnesium hydroxide (850 mg)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Water (150 ml)
Number of subjects: 6
Study: 6342562

Group type: EXPERIMENTAL
Intervention: Clomipramine hydrochloride
Number of subjects: 0

Group type: COMPARATOR
Intervention: Clorgyline hydrochloride
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 31283831

Group type: EXPERIMENTAL
Intervention: Sensory impairment (vision, hearing, dual)
Number of subjects: 213

Group type: EXPERIMENTAL
Intervention: Greater social engagement
Number of subjects: 213
Study: 29216745

Group type: EXPERIMENTAL
Intervention: Meditation
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Meditation then walk
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Walk then meditation
Number of subjects: 110

Group type: COMPARATOR
Intervention: Walk
Number of subjects: 110

Group type: COMPARATOR
Intervention: Control (inactive)
Number of subjects: 110
Study: 27077673

Group type: EXPERIMENTAL
Intervention: PEGylated‐interferonα2b (1.5 μg/kg/week) + ribavirin (800‐1400 mg/day) + boceprevir (800 mg TID)
Number of subjects: 64
Study: 24320105

Group type: EXPERIMENTAL
Intervention: Topical virgin coconut oil (VCO)
Number of subjects: 117

Group type: COMPARATOR
Intervention: Mineral oil
Number of subjects: 117
Study: 22909899

Group type: EXPERIMENTAL
Intervention: Oseltamivir-zanamivir bitherapy (O+Z)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Oseltamivir monotherapy (O)
Number of subjects: 24